The Business of Orthobiologics Podcast

Unlock the truth behind Orthobiologics: A Deep Dive On Techniques That Deliver Results in this eye-opening episode.

Cartilage Regeneration Isn’t What You Think → Visit the website to learn more https://pxllnk.co/AD/BOBsite

What if the real reason your cartilage treatments aren’t working has nothing to do with the injection itself? What if the science behind stem cells is far more misunderstood than most physicians realize? And what if the missing link to successful outcomes is hidden in the delivery, not the product? In this episode of Conversations in Regenerative Medicine, Dr. Ariana DeMers sits down with world-renowned orthopedic surgeon Dr. Dimitrios Tsoukas to explore Orthobiologics: A Deep Dive On Techniques That Deliver Results—and uncover the core challenges many clinicians silently struggle with.

In this in-depth interview, viewers get a structured, practical breakdown of the real obstacles behind cartilage pathology, including why cartilage is so notoriously difficult to regenerate, why common assumptions about stem cell therapy are incomplete, and how current regenerative medicine techniques—PRP therapy, BMAC, MFat, orthobiologic injections, and advanced cartilage repair approaches—fit into modern orthopedic decision-making. Dr. Tsoukas brings clarity to recurrent clinical questions: Can you regenerate cartilage? What is the role of adipose-derived products? Does mechanical axis correction still matter? When does microfracture fail? This episode provides a rare look into biologic, structural, and functional failures—and how expert clinicians merge science with technique to produce meaningful orthopedic healing. Throughout the conversation, the topic Orthobiologics: A Deep Dive On Techniques That Deliver Results is not just explored, but reframed, giving physicians practical insights they can implement immediately.

Viewers will also gain a clear, actionable overview of real-world regenerative strategies discussed in the video—ranging from cartilage regeneration treatment options to knee cartilage regeneration medicine, cartilage repair sequencing, senolytic support, emerging scaffolding technologies, and the surprising rise of auricular cartilage micrografting. Dr. Tsoukas shares clinical nuance behind patient selection, biologic product quality, dosing variability, standardization challenges, and why combining corrective surgery with biologics often produces superior outcomes. For clinicians seeking to understand how to treat cartilage damage, optimize regenerative cartilage treatment, or refine their approach to PRP treatment and platelet-rich plasma therapy, this conversation delivers a reasonable, experience-backed roadmap rooted in modern regenerative orthopedic practice. By the time the discussion concludes, the viewer has a complete narrative of Orthobiologics: A Deep Dive On Techniques That Deliver Results—from scientific foundations to practical execution.

If you’re a clinician, regenerative practitioner, or orthopedic provider aiming to elevate outcomes and stay ahead in the fast-growing field of medical innovation, this description is your gateway to a master-level discussion. Be sure to subscribe, like, comment, and connect with me directly for deeper training, hands-on workshops, and upcoming regenerative medicine events. 

Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.

Learn More here: https://thebusinessoforthobiologics.com/programs-explanation 

_______________________________________________________

Follow us and subscribe to our links below ⏬⏬⏬

Website: businessoforthobiologics.com
Apple Podcast: apple.co/3Azvt3R
Spotify: spoti.fi/3oICYmh
Youtube: bit.ly/drariana

PRP And Exosomes: Here's What Orthopedic Doctors Must Know to avoid confusion, elevate care, and navigate emerging science.

PRP Success Isn’t “Optional” Anymore →Visit my Website : https://pxllnk.co/AD/BOBsite

Are you unsure how to navigate the growing debate around PRP And Exosomes: Here's What Orthopedic Doctors Must Know? Are you wondering whether exosomes or platelet rich plasma therapy offer reliable, evidence-based outcomes? Are you frustrated about the regulatory gray zones, misinformation, or lack of standardization in regenerative medicine? In this conversation, I open up the most pressing and misunderstood topics shaping orthobiologics today so clinicians can finally gain clarity, confidence, and direction. Drawing directly from my discussion with Dr. Don Buford, we explore where exosomes truly stand, how PRP evidence is evolving, and what orthopedic doctors must realistically expect when integrating these therapies into practice. If you've been craving straightforward explanations on exosomes, exosome therapy, PRP injection pain management, or regenerative medicine orthopedics as a whole, this deep-dive will help you understand the landscape more clearly.

In this episode, we will walk you through the real-world insights from our fireside chat—from the hype surrounding exosomes explained in practical terms to the crucial distinctions between extracellular vesicles, autologous approaches, and the regulatory limitations surrounding their use. I share my personal perspective on how orthobiologics injections are being misinterpreted, why exosomes regenerative medicine is still in a formative stage, and what clinicians must consider before adding these treatments to a cash-based practice. You’ll hear exactly how PRP therapy continues to evolve, why platelet dose matters, and what we can fairly conclude from existing PRP evidence without making exaggerated claims. I also unpack how busy orthopedic, sports medicine, and interventional orthobiologics specialists can approach data collection, patient-reported outcomes, and practical quantification tools without feeling overwhelmed.

As I reflect on the video, I also highlight what Dr. Buford and I believe is coming next—including the future of research design, collaborative registries, orthobiologics standardization, and the essential mindset shift needed for successful practice integration. If you’ve ever felt uncertain about the legalities around exosomes, how to discuss biologics with patients, or how to build a profitable yet ethical regenerative medicine practice, this episode lays out a grounded and reasonable roadmap. Nothing here promises magic; instead, it provides realistic expectations, thoughtful insights, and strategies clinicians can apply immediately.

For more guidance on interventional orthobiologics, regenerative medicine, PRP training, and pain management orthopedic insights, make sure you connect with me directly. Subscribe, comment, like, and explore the other videos on my channel so you never miss the newest updates on orthobiologics, PRP injection explained breakdowns, exosomes, and evolving clinical strategies. 

Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.

Learn More here: https://thebusinessoforthobiologics.com/programs-explanation 

_______________________________________________________

Follow us and subscribe to our links below ⏬⏬⏬

Website: businessoforthobiologics.com
Apple Podcast: apple.co/3Azvt3R
Spotify: spoti.fi/3oICYmh
Youtube: bit.ly/drariana

Here's How Orthobiologics Is Revolutionizing Pain Management—transforming the way we treat musculoskeletal pain and optimize healing naturally.

Pain Relief, Redefined by Regeneration — Visit my Website https://pxllnk.co/AD/BOBsite

Are you struggling to find safer, more effective solutions for chronic pain? Wondering how regenerative medicine could change your orthopedic practice? Or maybe you’re curious about how to get into regenerative medicine but don’t know where to start? In this episode of Conversations in Regenerative Medicine, I dive deep into here's how orthobiologics is revolutionizing pain management—a powerful shift happening in modern healthcare. Joined by Dr. Annu Navani, a leader in orthopedic regenerative medicine, we unpack how orthobiologic treatments like PRP therapy and platelet-rich plasma injection are changing patient outcomes and reshaping how clinicians approach musculoskeletal care. From understanding the science behind orthobiologics to exploring medical practice innovations and orthopedic innovation, we uncover the real-world applications, challenges, and opportunities awaiting practitioners ready to embrace this next frontier. Whether you’re searching for regenerative medicine training, regenerative medicine courses online, or the right PRP training or PRP online course, this conversation offers a roadmap for stepping confidently into the future of pain management.

Throughout this episode, Dr. Navani shares how her transition from traditional interventional pain management to regenerative medicine evolved through years of research, innovation, and patient-centered practice. We explore the integration of orthobiologics with cutting-edge digital therapeutics, biomarkers, and longevity-focused medicine—all designed to optimize healing from the inside out. You’ll hear how clinicians can balance ethics, regulation, and innovation while staying at the forefront of orthopedic practice management. We also discuss how to build an evidence-based practice that thrives without relying on insurance models, and how to communicate transparently with patients about results, research, and realistic outcomes in orthobiologic treatments.

If you’ve ever asked yourself how to bring orthopedic regenerative medicine into your clinic, how to launch a cash-based model successfully, or how to expand through a regenerative medicine training program, this video is for you. Expect actionable insights, behind-the-scenes strategies, and empowering takeaways from one of the most respected leaders in the field. My goal is to help you bridge science, innovation, and patient care—so you can create real impact with every treatment.

Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.

Learn More here: https://thebusinessoforthobiologics.com/programs-explanation 

_______________________________________________________

Follow us and subscribe to our links below ⏬⏬⏬

Website: businessoforthobiologics.com
Apple Podcast: apple.co/3Azvt3R
Spotify: spoti.fi/3oICYmh
Youtube: bit.ly/drariana

Orthobiologics: are we overpromising PRP or under-educating patients sparks a vital discussion.

Stop Guessing, Start Leading Teams → Visit my Website https://pxl.to/AD/tq8nuql

Why do patients still default to steroids despite emerging regenerative medicine options? Are we failing in patient education, or is healthcare lacking transparency around informed decision making? And how do we balance patient needs with shared decision making in healthcare so that treatments like platelet rich plasma therapy (PRP) are presented realistically rather than as miracle cures?

In this fireside chat with Dr. Ariana Demers and Dr. Paul Tortland, we dive into the heart of orthobiologics, regenerative medicine, and the nuances of patient informed decision making. We explore how patient education in healthcare impacts choices, why transparency in healthcare is critical, and how both physicians and patients can work together through shared decision making in healthcare to avoid overpromising outcomes while still embracing innovation. From the ethics of steroid injections to the role of prp treatment in musculoskeletal care, this conversation unpacks the importance of educating patients about their real options. We also address how orthobiologics and regenerative medicine orthopedics could change long-term outcomes when combined with honest discussions about risks, limitations, and potential benefits.

Throughout the discussion, you’ll hear why orthobiologics—including platelet rich plasma therapy, prolotherapy, bone marrow concentrate, and micro-fragmented fat (MFAT)—require careful framing in patient conversations. We question whether physicians are under-educating patients or whether marketing has outpaced science, creating confusion and mistrust. By grounding the conversation in informed decision making in healthcare, Dr. Tortland and Dr. Demers provide insight into the real-world integration of regenerative treatments, highlighting the importance of educating patients about not just what orthobiologics can do, but also what they cannot. Viewers can expect open dialogue on ethical concerns, insurance barriers, and how patient informed decision making leads to better outcomes.

If you’re a clinician, patient, or someone curious about the evolving role of regenerative medicine, this video will help you understand the delicate balance between innovation and expectation. You’ll also discover why patient education in healthcare is not optional—it’s essential for guiding choices in a cash-based model where insurance rarely covers treatments like PRP. By the end, you’ll see how transparency in healthcare and a partnership approach can empower patients to make informed decisions about orthobiologics without false hope, while still accessing potential benefits of regenerative medicine orthopedics.

Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.

Learn More here: https://thebusinessoforthobiologics.com/programs-explanation 

_______________________________________________________

Follow us and subscribe to our links below ⏬⏬⏬

Website: businessoforthobiologics.com
Apple Podcast: apple.co/3Azvt3R
Spotify: spoti.fi/3oICYmh
Youtube: bit.ly/drariana

These are the ethical questions you should not ignore if you care about better patient outcomes.

Withholding orthobiologics is unethical → Visit My Website https://pxl.to/AD/tq8nuql

Are we unintentionally limiting patient access to life-changing care? Should regenerative treatments like orthobiologics remain cash-only? What happens when financial bias influences medical recommendations? In this in-depth discussion with Dr. Michael Khadavi, I explore the ethical questions you should not ignore in orthobiologic medicine and regenerative medicine. From the real-world challenges of PRP therapy and orthobiologics injections, to navigating PRP insurance coverage, we uncover how physicians can ethically integrate advanced treatments into a cash based medical practice without sacrificing accessibility or clinical integrity. You’ll hear our personal experiences transitioning from insurance-based models to cash based healthcare, weighing cash pay vs insurance, and how running a medical practice in today’s climate requires balancing innovation, patient needs, and profitability. Whether you’re building a medical practice from scratch or looking for ways on how to improve your medical practice, this conversation offers insight into orthopedic innovations, the realities of orthopedic medical services, and the business strategies that can help you thrive in a competitive healthcare landscape.

In this episode, you’ll discover how patient perception, value-based decision-making, and transparency shape success in a cash based medical clinic. We tackle the controversy of whether cash pay medical services shut out the average patient, and why we believe it’s unethical to withhold effective orthobiologics treatments simply because insurance won’t cover them. Through examples from my orthopedic medical practice, we discuss the surprising demographics that say “yes” to self-pay procedures and the practical systems for offering orthobiologics injections to all patients without making assumptions about their financial capability. You’ll also hear our strategies for ensuring clinical quality when scaling services—whether through physician extenders, leveraging AI for efficiency, or creating fellowship-level training to maintain standards in this fast-evolving field.

We also dive into the future of regenerative medicine, why orthopedic innovations like PRP therapy could be first-line treatments in the coming years, and how transparency in pricing can differentiate your orthopedic medical practice in a crowded market. You’ll gain a behind-the-scenes look at the mindset shifts required for building a cash based healthcare model that prioritizes patient autonomy while sustaining a profitable practice. This conversation is for any physician, practice manager, or healthcare entrepreneur who wants to lead the way in ethical, effective, and financially sound orthopedic medical services.

If you’re ready to rethink the way you approach orthobiologic medicine and regenerative care, this discussion will give you actionable ideas you can implement immediately. Watch until the end for tips on patient communication, overcoming business roadblocks, and creating systems that allow you to serve more people at a higher level. Connect with me to continue the conversation—leave a comment with your thoughts, like this episode, subscribe for more in-depth discussions, and explore the rest of my channel for strategies on running and improving your medical practice. Let’s keep pushing the boundaries of what’s possible in orthopedic innovations and cash pay medical services.

Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.

Learn More here: https://thebusinessoforthobiologics.com/programs-explanation 

_______________________________________________________

Follow us and subscribe to our links below ⏬⏬⏬

Website: businessoforthobiologics.com
Apple Podcast: apple.co/3Azvt3R
Spotify: spoti.fi/3oICYmh
Youtube: bit.ly/drariana

When it comes to hypermobility, here's what providers should know about their patients to improve outcomes.

Movement Before Needles—Always. → Visit My Website https://pxl.to/AD/tq8nuql

Why do some hypermobile patients keep coming back with the same injuries? Are we overlooking deeper connective tissue issues? And can regenerative treatments really make a long-term difference in stability and pain? In this conversation, we dive into hypermobility and here's what providers should know about their patients—from understanding the spectrum of hypermobility syndrome to tailoring hypermobility treatment strategies that address both physical and neurological factors. Drawing on years of experience treating complex connective tissue disorder cases, including ehlers-danlos syndromes, we explore realistic ehlers danlos syndrome treatment options, treatment for hypermobility, and practical insights for how to help hypermobility patients thrive.

I walk you through not just what is hypermobility, but also when movement therapy should take priority over injections, and where orthobiologics fit into the bigger picture. You’ll hear nuanced perspectives on regenerative medicine, regenerative medicine orthopedics, and how to match orthobiologic treatments—like regenerative injection therapy, regenerative joint therapy, and regenerative orthopedic medicine—to the right pathology. From identifying early warning signs in patient histories, to deciding between prolotherapy and PRP, to using supportive tools like orthotics and bracing, this episode is packed with practical takeaways that you can apply right away.

We also tackle the ethical side of treating hypermobility and EDS with limited research. You’ll learn why transparency in expectations is essential, how to differentiate between injury and pain, and the importance of integrating psychological support for patients with central sensitization. Whether you’re considering orthobiologics for shoulder instability in athletes, managing recurring joint subluxations, or simply trying to understand how to better evaluate and track hypermobile patients, this discussion gives you a deeper framework to guide decision-making.

By the end, you’ll have actionable strategies to improve diagnostic precision, select the right regenerative therapies, and create multi-disciplinary care plans that address both joint mechanics and nervous system sensitivity. This is not about promising miracles—it’s about making informed, ethical choices that can reasonably improve patient function and quality of life.

Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.

Learn More here: https://thebusinessoforthobiologics.com/programs-explanation 

_______________________________________________________

Follow us and subscribe to our links below ⏬⏬⏬

Website: businessoforthobiologics.com
Apple Podcast: apple.co/3Azvt3R
Spotify: spoti.fi/3oICYmh
Youtube: bit.ly/drariana

You’re Not Getting the Full Story in Regenerative Medicine: A Look at Transparency in Healthcare

Transparency Is Medicine’s Next Revolution – 🌐Visit my Website https://pxl.to/AD/tq8nuql

What aren’t patients being told about stem cell therapies? Are clinics offering orthobiologic treatments giving the full picture—or just part of it? And how can physicians responsibly navigate the murky global market of regenerative medicine: a look at transparency in healthcare?

In this episode of Conversations in Regenerative Medicine, I sit down with Dr. Rikin Patel, a thought leader in regenerative orthopedics and interventional orthobiologics. We dive into the evolving landscape of regenerative medicine, from autologous therapy and orthobiologics injections to allogeneic cell therapies and culture expanded stem cells being used in patient-funded clinical trials abroad. With patient transparency under scrutiny, this conversation brings clarity to what’s happening outside U.S. borders and what ethical considerations physicians must confront at home.

You’ll hear first-hand insight into the development and regulation of regenerative medicine in orthopedics—especially in relation to regenerative orthopedics and sports medicine. We cover hot-button topics like platelet rich plasma therapy (PRP), transparency in healthcare practices, the future of orthobiologic treatments, and how orthobiologics course knowledge can empower clinicians to offer better care. This episode unpacks the role of state laws, FDA oversight, and patient-funded research, all while spotlighting real-world scenarios doctors face in explaining orthobiologics to skeptical or overwhelmed patients.

If you’ve ever wondered whether it’s ethical—or even safe—for patients to travel abroad for stem cell treatments, or how to responsibly counsel your own patients on regenerative options, this discussion is for you. Dr. Patel shares his experience leading over 85 patients through a clinical trial in The Bahamas using up to 200 million allogeneic MSCs, while openly discussing the limitations, safety data, and consent protocols required. We also unpack how physicians can use systems and education—not “sales tactics”—to ethically introduce these options in cash-based models.

By the end of this episode, you’ll understand the importance of marrying regenerative medicine innovation with patient transparency—and why autologous therapy and orthobiologics still play a critical role as the field expands.

Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.

Learn More here: https://thebusinessoforthobiologics.com/programs-explanation 

_______________________________________________________

Follow us and subscribe to our links below ⏬⏬⏬

Website: businessoforthobiologics.com
Apple Podcast: apple.co/3Azvt3R
Spotify: spoti.fi/3oICYmh
Youtube: bit.ly/drariana

Discover Why Orthobiologics Are The Future of Joint & Musculoskeletal Pain.

Be part of the Orthobiologics Masterclass - Visit https://pxl.to/AD/tq8nuql

Are you overwhelmed by the complex choices in regenerative treatments? Wondering which patients are the right candidates for advanced regenerative orthopedics? Curious how to confidently integrate orthobiologics into your practice without relying on insurance-based models?

In this in-depth episode of Conversations in Regenerative Medicine, I sit down with Dr. Chris Rogers—renowned expert in physical medicine and rehabilitation—to uncover the evolving science behind the Orthobiologics and DataBiologics breakthrough. This episode dives into the power of platelet rich plasma, the promise of culture-expanded adipose-derived stem cells, and the practical application of regenerative medicine in clinical practice. Whether you're curious about how to leverage regenerative orthopedics in a cash-based practice or need clarity on patient selection, this conversation provides valuable insight without overhyping results.

You'll hear firsthand how PRP therapy evolved from guesswork to guided outcomes, thanks to real-time patient tracking through the DataBiologics registry. We discuss how evidence-backed regenerative medicine is gaining traction as a first-line option for musculoskeletal care, and what this means for the future of orthobiologics. From early-stage challenges to long-term outcome trends, we share stories, data, and strategies that help bridge science with practical clinical decisions. You'll also learn about misconceptions around stem cell science, including key differences between stromal vascular fraction, MFAT, and culture-expanded cells—and how regulatory pathways like FDA clinical trials shape treatment access.

Plus, I reveal a few tools and resources—like the Regen Patient Magnet Method—that have helped me and others successfully integrate regenerative medicine orthopedics into our workflows, with an emphasis on quality outcomes and ethical transparency. Whether you're just getting started or aiming to grow your breakthrough regenerative orthopedics practice, this episode equips you with perspectives that matter.

Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.

Learn More here: https://thebusinessoforthobiologics.com/programs-explanation 

_______________________________________________________

Follow us and subscribe to our links below ⏬⏬⏬

Website: businessoforthobiologics.com
Apple Podcast: apple.co/3Azvt3R
Spotify: spoti.fi/3oICYmh
Youtube: bit.ly/drariana

Are we truly helping patients heal—or just selling hope? Are we overpromising healing results to our patients in the booming field of orthobiologics? And if cultured stem cells really offer better outcomes, why can’t we use them in the U.S. yet? These are the difficult but necessary questions we dive into in this eye-opening episode of Conversations in Regenerative Medicine featuring Dr. John Pitts.

In this candid and richly informative discussion, we explore the promises and pitfalls of regenerative medicine, particularly in the context of platelet rich plasma injection (PRP), bone marrow concentrate (BMC), and cultured mesenchymal stem cells. Are we, as providers, genuinely guiding our patients to the best available treatment—or are we too often navigating the gray zone between science and marketing? With a market now worth $4 billion, orthobiologics is under more scrutiny than ever, and the question lingers: are we overpromising healing results to our patients?

Dr. Pitts shares his nuanced experience in regenerative orthopedics and sports medicine, unpacking how regenerative treatments can be powerful—but only when used with precision, transparency, and the right patient profile. We break down the current PRP therapy and stem cell research, compare intraosseous versus intraarticular injections, and discuss whether we’re ready for global guidelines or still stuck in the “wild west” of regenerative medicine. We also reflect on the ethical implications of access, affordability, and whether withholding regenerative care because of insurance limitations is, in itself, unethical.

You’ll hear real clinical insights from over a decade of advanced regenerative orthopedics work, as well as practical takeaways on patient communication, outcome tracking, and the delicate balance between data, hope, and honesty. This is a must-watch for any practitioner navigating the challenges and breakthroughs of regenerative medicine orthopedics today.

If you’re passionate about staying ahead in regenerative orthopedics—or simply want a clearer framework to counsel your patients—this conversation delivers clarity without hype.

Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.

Learn More here: https://thebusinessoforthobiologics.com/programs-explanation 

_______________________________________________________

Follow us and subscribe to our links below ⏬⏬⏬

Website: businessoforthobiologics.com
Apple Podcast: apple.co/3Azvt3R
Spotify: spoti.fi/3oICYmh
Youtube: bit.ly/drariana

What if you could finally understand how to use orthobiologics and peptides without crossing regulatory lines? What’s stopping your clinic from offering peptides for healing joints in a legal and efficient way? And how do you actually combine regenerative medicine with real-world protocols for better patient outcomes? In this conversation with Dr. Roddy McGee, I sit down to dissect what clinics need to know right now if they want to successfully adopt orthobiologic therapy, peptides for injury recovery, and regenerative tools like PRP injections without getting lost in compliance chaos.

If you’re a practitioner already offering PRP or exploring regenerative medicine in orthopedics, this video gives you a front-row seat to the nuances of peptides therapy—what works, what’s legal, what’s next. We talk about real cases, where peptides like BPC-157 and TB-500 may actually help in tissue healing, what stacks are showing promise for tendon and joint recovery, and what’s hype versus what’s helpful. Dr. McGee walks through the logistics—storage, patient guidance, sourcing compounds, and how to start slow while planning for what may soon become standard of care.

You’ll also hear the honest truth about the hurdles clinics face—why sourcing best peptides for healing injuries isn’t straightforward, how evolving FDA guidelines complicate implementation, and how to prepare your practice now to pivot quickly as laws change. I also touch on the systems we’ve built—from consults to cash-based pricing—to help physicians transition into regenerative medicine with clarity and structure.

Whether you’re looking to accelerate muscle tear recovery or simply want a smarter workflow for PRP online courses and injections, this conversation gives you an inside look. If you’ve been curious about “what is orthobiologics” and how it ties into peptides for injury—this is where you start.

Ready to get real with your practice? Let’s connect! Subscribe for more no-fluff insights, like this episode, leave a comment with your biggest takeaway, and check out other interviews on the channel.

Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.

Learn More here: https://thebusinessoforthobiologics.com/programs-explanation 

_______________________________________________________

Follow us and subscribe to our links below ⏬⏬⏬

Website: businessoforthobiologics.com
Apple Podcast: apple.co/3Azvt3R
Spotify: spoti.fi/3oICYmh
Youtube: bit.ly/drariana